# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 05-15-2024 | 03-31-2024 | 10-Q | |
2 | 04-01-2024 | 12-31-2023 | 10-K | |
3 | 11-20-2023 | 09-30-2023 | 10-Q | |
4 | 08-25-2023 | 06-30-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Aims To Comply With Nasdaq $1.00 Minimum Bid Price Requirement; Trading To Continue Under Symbol "SXTP" With New CUSIP ...
60 Degrees Pharmaceuticals Inc. (NASDAQ: SXTP) shares are surging on Friday following the company's announcement of clinica...
The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tuft...